perhexiline has been researched along with nifedipine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (75.68) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (5.41) | 29.6817 |
2010's | 7 (18.92) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keserü, GM | 1 |
Jia, L; Sun, H | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Sen, S; Sinha, N | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Short, D | 1 |
Castaño Bazo, L; de Castro del Pozo, S; Delcán, JL; Ledesma García, C; Martín Luengo, C; Pabón Osuna, P; Sala Sánchez-Castillo, A; Santos Rodríguez, I | 1 |
Sowton, E | 1 |
Breithaupt, H; Walter, P | 1 |
Affaki, GS; Bonan, R; Crittin, J; Mizgala, HF; Théroux, P; Waters, DD | 1 |
Adamska-Dyniewska, H; Dziekański, S | 1 |
Atkins, C; Bax, M; Psychoyos, S | 1 |
Martre, H; Singlas, E; Taburet, AM | 1 |
Briscoe, MG; Smith, HJ | 1 |
Barry, WH; Horowitz, JD; Smith, TW | 1 |
Opie, LH | 1 |
Fossati, C; Guistiniani, S | 1 |
Lewis, JG | 1 |
Donath, M; Ebner, F; Rämsch, KD | 1 |
Feely, J; Maclean, D | 1 |
Becker, HJ; Dowinsky, S; Hopf, R; Kaltenbach, M; Kober, G | 1 |
Forman, R; Kirk, ES | 1 |
Dipalma, JR | 1 |
Edvinsson, L; Johansson, BB; Larsson, B; MacKenzie, ET; Skärby, T; Young, AR | 1 |
Hochrein, H; Lehmann, HU | 1 |
Antman, EM; Braunwald, E; Muller, JE; Stone, PH | 1 |
Hayakawa, H; Kimura, E; Kishida, H; Kusama, Y; Otsu, F; Takayama, M | 1 |
Kimura, M; Ono, H | 1 |
Bergey, JL; McCallum, JD; Nocella, K | 1 |
Nayler, WG | 1 |
Flaim, SF; Zelis, R | 1 |
Aziza, JP; Blanchard, D; Guermonprez, JL; Lancelin, B; Maurice, P | 1 |
9 review(s) available for perhexiline and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of angina pectoris (III)].
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Artery Bypass; Humans; Nifedipine; Perhexiline; Prenylamine; Vasodilator Agents; Verapamil | 1979 |
[Clinical pharmacology of calcium inhibitors].
Topics: Age Factors; Animals; Bepridil; Biological Availability; Biotransformation; Calcium Channel Blockers; Diltiazem; Dogs; Half-Life; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Liver Diseases; Metabolic Clearance Rate; Nifedipine; Perhexiline; Protein Binding; Pyrrolidines; Rats; Tissue Distribution; Verapamil | 1985 |
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendiline; Gastrointestinal Diseases; Humans; Lidoflazine; Nervous System Diseases; Nifedipine; Perhexiline; Prenylamine; Verapamil | 1984 |
Adverse reactions to calcium antagonists.
Topics: Calcium Channel Blockers; Diltiazem; Drug Interactions; Humans; Kinetics; Lidoflazine; Nifedipine; Perhexiline; Prenylamine; Risk; Verapamil | 1983 |
Clinical differentiation of nifedipine and other calcium antagonists.
Topics: Biological Availability; Calcium Channel Blockers; Diltiazem; Drug Tolerance; Heart Diseases; Hemodynamics; Humans; Kinetics; Nifedipine; Perhexiline; Verapamil | 1984 |
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; Exercise Test; Fendiline; Humans; Nicardipine; Nifedipine; Perhexiline; Prenylamine; Propafenone; Propiophenones; Verapamil | 1982 |
[Indications for use of calcium antagonists].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Coronary Disease; Female; Fendiline; Humans; Hyperinsulinism; Hypertension; Nifedipine; Obstetric Labor, Premature; Paraganglioma; Perhexiline; Pregnancy; Prenylamine; Vasodilator Agents; Verapamil | 1980 |
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.
Topics: Benzazepines; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Circulation; Diltiazem; Hemodynamics; Humans; Myocardial Contraction; Nifedipine; Nitrogen; Perhexiline; Piperidines; Pyridines; Regional Blood Flow; Vasodilation; Verapamil | 1980 |
28 other study(ies) available for perhexiline and nifedipine
Article | Year |
---|---|
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Humans; Isosorbide Dinitrate; Nifedipine; Nitroglycerin; Perhexiline | 1978 |
[Physiopathological and therapeutical considerations of Prinzmetal's angina. Apropos of 7 cases].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Coronary Vessels; Electrocardiography; Humans; Male; Middle Aged; Nifedipine; Perhexiline; Vasodilator Agents | 1979 |
The treatment of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Angiography; Humans; Isosorbide Dinitrate; Middle Aged; Nifedipine; Nitroglycerin; Perhexiline; Physical Exertion; Prenylamine; Verapamil | 1979 |
Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Electrocardiography; Ergonovine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Nifedipine; Perhexiline; Piperidines; Pyridines | 1979 |
Drug treatment of chronic stable angina pectoris.
Topics: Angina Pectoris; Chronic Disease; Humans; Nifedipine; Nitrites; Perhexiline; Verapamil | 1978 |
[Comparative studies on perhexiline, nifedipine and practolol in the light of spirometric and ergometric examinations].
Topics: Coronary Disease; Humans; Nifedipine; Perhexiline; Physical Exertion; Piperidines; Practolol; Pyridines; Spirometry | 1978 |
Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brain.
Topics: Adenine; Adenosine; Animals; Arrhythmias, Cardiac; Brain Chemistry; Calcium Channel Blockers; Cell Membrane; Cyclic AMP; Epinephrine; Guinea Pigs; In Vitro Techniques; Nifedipine; Perhexiline; Prenylamine; Receptors, Adrenergic; Receptors, Cell Surface; Receptors, Purinergic; Stereoisomerism; Tritium; Verapamil | 1986 |
The relative sensitization by acidosis of five calcium blockers in cat papillary muscles.
Topics: Acidosis; Animals; Calcium Channel Blockers; Cats; Diltiazem; In Vitro Techniques; Lidoflazine; Myocardial Contraction; Nifedipine; Papillary Muscles; Perhexiline; Verapamil | 1985 |
Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Chick Embryo; Gallopamil; Half-Life; Lidoflazine; Myocardial Contraction; Myocardium; Nifedipine; Perhexiline; Time Factors; Verapamil | 1985 |
Drugs and the heart. III. Calcium antagonists.
Topics: Angina Pectoris; Aniline Compounds; Arrhythmias, Cardiac; Calcium; Cardiomegaly; Diuretics; Heart Diseases; Heart Failure; Humans; Hypertension; Indapamide; Nifedipine; Perhexiline; Piperidines; Pyridines; Verapamil | 1980 |
Calcium antagonists, nitrates, and new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Isosorbide Dinitrate; Lidoflazine; Nifedipine; Nitrates; Nitroglycerin; Perhexiline; Prenylamine; Tachycardia; Verapamil | 1983 |
Comparative effects of vasodilator drugs on large and small coronary resistance vessels in the dog.
Topics: Animals; Coronary Vessels; Dogs; Nifedipine; Nitroglycerin; Nitroprusside; Perhexiline; Vascular Resistance; Vasodilator Agents; Verapamil | 1980 |
Calcium channel blockers.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Half-Life; Heart Diseases; Humans; Hypertension; Kinetics; Myocardial Infarction; Nifedipine; Perhexiline; Vasodilator Agents; Verapamil | 1983 |
Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Calcium Channel Blockers; Cerebrovascular Circulation; Ethanol; Male; Nicotinic Acids; Nifedipine; Nimodipine; Perhexiline; Rats; Rats, Inbred Strains; Xenon Radioisotopes | 1983 |
Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina.
Topics: Aged; Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Vasospasm; Diltiazem; Female; Humans; Male; Middle Aged; Nifedipine; Perhexiline; Prenylamine; Pyridines; Rest; Verapamil | 1982 |
Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
Topics: Adenosine Diphosphate; Adolescent; Adult; Calcium; Collagen; Diltiazem; Epinephrine; Humans; In Vitro Techniques; Male; Nifedipine; Perhexiline; Platelet Aggregation; Vasodilator Agents; Verapamil | 1981 |
Antiarrhythmic evaluation of verapamil, nifedipine, perhexiline and skf 525-A in four canine models of cardiac arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Calcium; Dogs; Female; Heart Rate; Lidocaine; Male; Myocardial Contraction; Nifedipine; Perhexiline; Piperidines; Proadifen; Pyridines; Verapamil | 1981 |
Calcium antagonists.
Topics: Angina Pectoris; Calcium Channel Blockers; Cell Membrane; Diltiazem; Heart; Humans; Hypertension; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Infarction; Myocardium; Nifedipine; Perhexiline; Verapamil | 1980 |
Clinical use of calcium entry blockers.
Topics: Angina Pectoris; Calcium Channel Blockers; Cinnarizine; Coronary Circulation; Coronary Vasospasm; Diltiazem; Flunarizine; Heart Rate; Humans; Lidoflazine; Nifedipine; Perhexiline; Verapamil | 1981 |
[Calcium inhibitors. Current indications in cardiology].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium; Cardiovascular Diseases; Diltiazem; Humans; Nifedipine; Perhexiline; Prenylamine; Verapamil | 1980 |